News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zhifei Biological Products Expands Vaccine Partnership With Merck & Co., Inc. (MRK)


6/11/2012 9:55:19 AM

by Richard Daverman, PhD

June 8, 2012 -- Chongqing Zhifei Biological Products and Merck signed an MOU that expands the existing partnership between the two companies by entrusting Zhifei with the responsibility for China marketing of Merck’s RotaTeq, an oral pentavalent live rotavirus vaccine. Merck, known as MSD outside the US and Canada, already sells the vaccine in 85 countries. Last year, Zhifei took over the China marketing of Merck’s MMR/rubella and Penumovax 23 vaccines. More details....

Stock Symbols: (SHE: 300122) (NYSE: MRK)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES